LP
INFI

LMR Partners’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

LMR Partners’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-41,631
Closed -$50K – 1395
2022
Q3 		$50K Hold
41,631
– – ﹤0.01% 1100
2022
Q2 		$26K Buy
+41,631
New +$32K ﹤0.01% 1221
2021
Q2 		– Sell
-30,531
Closed -$99K – 1410
2021
Q1 		$99K Buy
+30,531
New +$102K ﹤0.01% 858
2017
Q3 		– Sell
-141,526
Closed -$222K – 591
2017
Q2 		$222K Buy
+141,526
New +$273K 0.01% 511

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

LMR Partners's INFI Position: Q4 2022 in Review

LMR Partners sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2022, closing a stake of 41,631 shares — an estimated $50K sold.

LMR Partners first reported a position in INFI in Q2 2017 and held it in 4 quarters. The position peaked at $222K in Q2 2017. 68 funds tracked by Wall St. Rank hold INFI as of Q4 2022.

  • LMR Partners reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • LMR Partners sold 41,631 Infinity Pharmaceuticals, Inc. shares in Q4 2022, an estimated $50K.
  • LMR Partners first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2017 and held it in 4 quarters.
  • LMR Partners's Infinity Pharmaceuticals, Inc. position peaked at $222K in Q2 2017.
  • 68 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2022.

Based on LMR Partners's 13F filing for Q4 2022, filed 14 Feb 2023.